Curcumin decreased level of proinflammatory cytokines in monocyte cultures exposed to preeclamptic plasma by affecting the transcription factors NF-κB and PPAR-γ  by Rahardjo, Bambang et al.
Biomarkers and Genomic Medicine (2014) 6, 105e115Available online at www.sciencedirect.com
ScienceDirect
journal homepage: www.j -bgm.comORIGINAL ARTICLECurcumin decreased level of
proinflammatory cytokines in monocyte
cultures exposed to preeclamptic plasma by
affecting the transcription factors NF-kB and
PPAR-g
Bambang Rahardjo a,*, Edy Widjajanto b, Hidayat Sujuti c,
Kusnarman Keman da Doctorate Program of Biomedics, Faculty of Medicine, Dr. Saiful Anwar General Hospital,
Brawijaya University of Malang, Indonesia
b Clinical Pathology Department, Dr. Saiful Anwar General Hospital, Faculty of Medicine,
Brawijaya University of Malang, Indonesia
c Biochemistry Department, Dr. Saiful Anwar General Hospital, Faculty of Medicine,
Brawijaya University of Malang, Indonesia
d Division of MaternaleFetal Medicine, Department of Obstetrics and Gynecology, Faculty of Medicine,
Brawijaya University of Malang, IndonesiaReceived 9 April 2014; received in revised form 8 June 2014; accepted 12 June 2014
Available online 6 August 2014KEYWORDS
curcumins;
monocyte cultures;
preeclamptic plasma;
proinflammatory
cytokines* Corresponding author. Division of M
of Malang, Jaksa Agung Suprapto Stre
E-mail address: rahardjobambang1
http://dx.doi.org/10.1016/j.bgm.201
2214-0247/Copyright ª 2014, TaiwanAbstract The purpose of this study is to determine the role of curcumin in the alteration of
levels of interleukin (IL)-1a, IL-6, and tumor necrosis factor a (TNF-a) as proinflammatory cy-
tokines in monocyte culture exposed to preeclamptic plasma, as well as the effect on the tran-
scription factors: nuclear factor kappa beta (NF-kB) and peroxisome proliferator-activated
receptor g (PPAR-g). Plasma was taken from preeclamptic women (nZ 12) and normotensive
pregnant women (n Z 12). Monocyte cultures were taken from nonpregnant healthy woman.
Monocyte cultures were incubated with plasma for 48 hours. Curcumin in various doses were
given in monocytic cultures prior to and after preeclamptic plasma exposure. The levels of
IL-1a, IL-6, and TNF-a as well as NF-kB and PPAR-g in each culture were determined by
enzyme-linked immunosorbent assay procedures. The final data were analyzed by analysis
of variance (ANOVA) and path analysis. This study shows a significant increase (p < 0.05) in
the levels of proinflammatory cytokines (IL-1a, IL-6, and TNFa) in monocyte cultures exposedaternaleFetal Medicine, Department of Obstetrics and Gynecology, Dr. Saiful Anwar General Hospital
et 2, Malang 65111, East Java/Faculty of Medicine, Brawijaya University of Malang, Indonesia.
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106 B. Rahardjo et al.to preeclamptic plasma compared with normotensive pregnancy plasma. Curcumin treatment
in various doses can decrease significantly (p < 0.05) proinflammatory cytokine levels in mono-
cyte cultures that have been already stimulated by preeclamptic plasma. After curcumin
treatment, there was a decreased level of nuclear NF-kB p50 and a significantly increased level
of PPAR-g. Curcumin has a direct effect on decreasing the levels of nuclear NF-kB p50 and also
curcumin indirectly influenced the level of nuclear NF-kB p50 by the increased level of PPAR-g.
Curcumin could decrease levels of proinflammatory cytokines (IL-1a, IL-6, and TNFa) in mono-
cyte cultures exposed to preeclamptic plasma by affecting the transcription factors, NF-kB and
PPAR-g. Curcumin has potential in the prevention and future treatment of preeclampsia,
through inflammation pathways assumed as being responsible for the development of pre-
eclampsia.
Copyright ª 2014, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier
Taiwan LLC. All rights reserved.Introduction
Preeclampsia is responsible for a great morbidity and mor-
tality ofmaternalefetal casesworldwide. It occurs in 5e8%of
pregnancies, and the number has increased in developing
countries. Themechanism of preeclampsia is formed through
several pathways; the abnormality of vascular invasion by the
cytotrophoblast, the disorder of tone vascularity, immu-
nology disturbance, genetic anomaly, and inflammation
theory.1e3 Various concepts of the pathogenesis of pre-
eclampsia have been widely described, but the characteris-
tics of preeclampsia remain the same: an excessive systemic
inflammation and endothelial dysfunction.4e11 However, the
pathogenesis of the disease is not completely understood, a
generalized inflammatory response is suggested to play an
important role in thepathogenesis. Endothelial dysfunction is
characterized by elevated levels of factor VIII, total and
cellular fibronectin, thrombomodulin, endothelin, growth
factor activity, and impaired balance tPA/PAI-1 and prosta-
cyclin/tromboxan-A2.5,11e15
One source of the increases in proinflammatory cyto-
kines in preeclampsia is the placenta that release cytokines
into the circulation of women with preeclampsia. Another
source of proinflammatory cytokines in preeclampsia is
monocytes/macrophages, which are the main reserve of
proinflammatory cytokines and are the first cells activated
in nonspecific immune responses.8,10,12,13,16 The role of
proinflammatory cytokines in preeclampsia is based on the
observation that the plasma levels of tumor necrosis factor
a (TNF-a) and interleukin (IL)-6 increases in women with
preeclampsia. Maternal circulating monocytes have the
ability to produce proinflammatory cytokines of IL-1b, TNF-
a, IL-6, and IL-8 in patients with preeclampsia.9,13,14,16
There are many substances which can stimulate an in-
flammatory response in normal pregnancy and preeclamp-
sia, such as, angiogenic factor, cytokines, product of
oxidative stress, and microparticle trophoblasts.4,12,17 Faas
et al18, in their 2008 study show that plasma from normal
pregnancy and preeclampsia could activate monocytes
in vitro.16,19e22
The inflammatory response involves various transcrip-
tion factors. One transcription factor that plays an impor-
tant role in the inflammatory response is nuclear factorkappa beta (NF-kB). NF-kB is a major regulator and initiator
of the inflammatory response.23e25 Most mediators of
inflammation are regulated by NF-kB, including proin-
flammatory cytokines, chemokines, adhesion molecules,
enzymes, and kinases. Activated NF-kB often work together
with other transcription factors such as Activating Protein-1
(AP-1) and PPAR-g. Materials capable of giving the effect of
downregulation of NF-kB and NF-kB-regulated gene prod-
ucts have potential effects for use in the treatment of
various diseases.25,26 In addition to the transcription factor
NF-kB, nuclear hormone receptor PPAR has an important
role in regulating the inflammatory response. PPAR belongs
to a family of nuclear hormone receptors expressed in
various tissues including cells of the immune system.27e29
PPAR ligands can inhibit the expression of genes that play
a role in inflammation such as TNF-a, IL-6, inducible nitric
oxide synthetase, metalloproteinase 9, and scavenger re-
ceptor A. PPAR ligands have anti-inflammatory actions by
inhibiting various transcription factors such as NF-kB at
various levels. Activation of PPAR generally has anti-
inflammatory effects.29e31 It was thought that any kind of
sources stimulate downregulation of NF-kB and other genes
regulated by NF-kB have potential effects which can be
used in treatments related to inflammation.32e34
Curcumin (diferuloylmethane) is a kind of polyphenol
which produces the yellow color of turmeric.35 Turmeric
(Curcuma longa) is a plant of the ginger family, Zingiber-
aceae, generally grown in Southern and Southeast Asia.
During the past 2 decades, many studies demonstrated
various biologic and pharmacologic activities of curcumin as
anticarcinogenic, antimalarial, antioxidant, antimutagenic,
antibacterial, antiangiogenic, immune-modulatory, che-
moprotective, and anti-inflammatory agent. Curcumin has
many molecular targets such as transcription factors, en-
zymes, growth factors, receptors, genes expression, kinase,
etc.36e39
Many concepts have revealed the pathogenesis of
preeclampsia, nevertheless, the exaggeration of systemic
inflammation and endothelial dysfunction are still
considered as the most reliable background in pre-
eclampsia.7,11,14,15 It inspired the research of the anti-
inflammatory effect of curcumins related to
preeclampsia.
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Participants
The study was conducted in Dr. Saiful Anwar Hospital,
Malang, Indonesia and the Physiology Laboratory of Medical
Faculty, Brawijaya University, Jalan Veteran, Indonesia
from April 2013 to September 2013. Monocyte cultures were
taken from the peripheral blood mononuclear cells (PBMC)
of healthy and nonpregnant women. Plasma was taken from
12 normotensive primigravidae within 34 weeks of gestation
and 12 severe preeclampsia (late onset) with the exclusion
criteria: pregnant women with chronic hypertension, dia-
betes mellitus, hypercholesterolemia and hyperlipidemia,
infectious diseases, kidney diseases, and in labor.
Recruitment of participants was approved by the
ethical committee of Dr. Saiful Anwar Hospital with pa-
tients’ informed consent. The study commenced with
comparing the levels of IL-1a, IL-6, and TNF-a as well as
the levels of PPAR-g and nuclear NF-kB p50 in monocyte
culture exposed to normotensive pregnancy plasma and
those exposed to preeclamptic plasma. In this way,
monocyte cultures derived from nonpregnant healthy
woman were divided into two groups: the first group
received 15% normotensive pregnancy plasma which was
incubated for 48 hours, whereas the second group
received 15% preeclamptic plasma which was also incu-
bated for 48 hours.
In the main study, two steps were performed which
were distinguished from each other in the time of giving
curcumin extract and preeclamptic plasma into monocyte
cultures. In Step 1, the levels of IL-1a, IL-6, and TNF-a as
well as PPAR-g and nuclear NF-kB p50 were compared in
four groups of monocyte cultures: control group (without
any curcumin treatment) and treatment groups (with
doses of 10mM, 30mM, and 100mM of curcumins which were
all exposed to 15% preeclamptic plasma and incubated for
48 hours at 37C, 95% O2 and 5% CO2.Meanwhile, in Step 2
of the study, the levels of IL-1a, IL-6, and TNF-a as well as
PPAR-g and nuclear NF-kB p50 were compared in four
groups of monocyte cultures which were all exposed to
15% preeclamptic plasma at first and then incubated for
48 hours at 37C, 95% O2, and 5% CO2. After preeclamptic
plasma exposure, curcumins were given (with curcumin
doses of 10mM, 30mM, and 100mM) to the culture for 1 hour
in the treatment groups. The levels of IL-1a, IL-6, and
TNF-a as well as PPARg and nuclear NF-kB p50 was
measured by enzyme-linked immunosorbent assay
(ELISA).
Isolation of PBMC and culture of monocytes
A 10-mL sample of whole blood was taken out of heparin
Vacutainer and transferred to a falcon tube. Percoll solu-
tion was prepared as follows. Initially, it was prepared with
Ficoll-Hypaque gradient (density Z 1.070 g/mL) and then
with a small amount of hyperosmolar Percoll gradient
(density Z 1.064 g/mL). Isosmotic Percoll was prepared by
mixing one volume of 1.5M NaCl with nine volumes of Per-
coll (Pharmacia, density Z 1.130 g/mL). Percoll gradient
was prepared by mixing 1:1 (v/v) isosmotic Percoll withPBS/citrate (NaH2PO4 1:49mM; Na2HPO4 9.15mM; NaCl
139.97mM; C6H5Na3O7.2H2O 13 mm; pH 7.2).
Both of the gradients were centrifuged at 2535C at
400g for 35 minutes. The percentage of monocytes after
Percoll gradients was 90% greater by using histochemical
morphology and Fluorescence activated cell sorting (FACS)
analysis. The desired cells then appeared and monocytic
cells in suspension or attached to plastics were harvested.
There were 8090% monocytes in the culture of mono-
cytes. The cells were cultured in the same media with the
addition of 10% fetal bovine serum (FBS; Gibco BRL); the
media was referred to as RPMI-FBS. Monocytes were
cultured for 24 hours and 48 hours at 37C with 5% CO2.
Subsequently, cells could be harvested (Gibco BRL e San
Fransisco/USA; R&D Systems e Minneapolis/USA).
Quantitative measurement of the levels of
proinflammatory cytokines and transcription
factors
The level of IL-1a (Human IL-1a ELISA kit, R&D Systems), IL-6
(Human IL-6 ELISA kit, R&D Systems), TNF-a (Human TNF-a
ELISA kit, R&D Systems), NF-kB p50 (NF-kB p50 ELISA kit,
Signosis No. TE-0002; Signosis Inc.), and peroxisome
proliferator-activated receptor g (PPAR-g ELISA kit, Signosis
No. 0009; Signosis Inc.) in monocyte cultures were deter-
mined using ELISA. Assays were performed as described by
the manufacturers. Optical density (OD) was measured
spectrophotometrically at a wavelength of 450 2 nm for 30
minutes. Samples and standards weremeasured in duplicate
and the mean values were calculated. The final results were
expressed as pg/mL (R&D Systems e Minneapolis/USA;
Signosis Inc. e Santa Clara/USA).
Statistical analysis
For statistical analysis, we used SPSS version 19 (SPSS Inc.,
Chicago, IL, USA).
Comparison tests by one-way ANOVA
Hypothesis testing of multiple mean variances was per-
formed using one-way analysis of variance (ANOVA) to
compare response variables among the treatment groups
and subsequently by using multiple comparison tests with
the least significant difference tests.
Path analysis
Path analysis was used to show the significant relationship
between curcumin and the level of proinflammatory cyto-
kines and also transcription factor NF-kB p50 and PPAR-g.
Results
Based on the inclusion and exclusion criteria, the data were
obtained from a total of 12 normotensive patients and 12
patients with preeclamptic plasma samples with the char-
acteristics of the study participants described in Table 1.
Table 1 Characteristics of participants.
Characteristics Normal (n Z 12) Preeclampsia (n Z 12) p
Age (y) 25.08  5213.00 29.00  6045.00 0.103
Systole (mmHg) 110.67  7.60 168.33  11.15 <0.001*
Diastole (mmHg) 72.25  7.96 106.67  6.51 <0.001*
Gestational age (wk) 36.50  1.62 38.08  1.00 0.009*
BMI 27.54  4.77 33.26  7.70 0.014*
Leukocytes (no./ul) 9,583.25  2,222.68 12,890.83  3,400.87 0.010*
Platelets (no./ul) 324,166.67  101,332.79 284,916.67  70,363.29 0.671
Uric acid (mg/dl) 4.16  0.91 6.23  1.32 <0.001*
Birth weight (g) 2965.67  487.16 2721.42  770.18 0.363
Proteinuria Negative (n Z 12) 2þ (n Z 3)
3þ (n Z 9)
e
Mode of delivery ND (n Z 9)
LSCS (n Z 3)
LSCS (n Z 11)
ND (n Z 1)
e
*A p value < 0.05 means that there is a significant difference.
BMI Z body mass index; LSCS Z low segment cesarean section; ND Z normal delivery.
108 B. Rahardjo et al.Comparison of the levels of proinflammatory
cytokines (IL-1a, IL-6, and TNF-a), PPAR-g, and
nuclear NF-kB p50 in monocyte cultures exposed to
normotensive pregnancy plasma with those
exposed to severe preeclamptic plasmadincubated
for 48 hours
In this study, significant differences were found in the levels
of proinflammatory cytokines IL-1a, IL-6, and TNF-a, and
levels of nuclear NF-kB p50 in monocyte cultures exposed to
normotensive pregnancy plasmaand those exposed to severe
preeclamptic plasma, with the latter having higher levels
(p < 0.05). However, there was a significant decrease in
PPAR-g levels (p < 0.05), as shown in Table 2.The effect of giving various doses of curcumins on
the level of proinflammatory cytokines (IL-1a, IL-6,
and TNF-a) in monocyte cultures prior to
preeclamptic plasma exposure
In Step 1 of the study, we found a significant difference
(p < 0.05) in the level of IL-1a in monocyte cultures
which had been treated with 100mM curcumin, whereas
the monocyte culture without curcumin showed a much
lower level of IL-1a. The level of IL-1a did not show a
significant difference with 10mM and 30mM curcumin
doses (p > 0.05).
We also found that the level of IL-6 which was treated
with curcumin 30mM decreased significantly (p > 0.05).
However, if it was compared to those treated with curcu-
min 10mM as well as 100mM, there was no significant
difference.
Compared to the control group, there was a significant
decrease in the level of TNF-a found in monocyte cultures
receiving curcumin at doses of 30mM and 100mM, mean-
while, there was no significant alteration in the variety of
curcumin doses (p > 0.05), as shown in Fig. 1 or Table S1 in
the supplementary material online.The effect of giving various doses of curcumins to
the level of PPAR-g and nuclear NF-kB p50 in
monocyte cultures prior to preeclamptic plasma
exposure
In Step 1 of the study, a significant difference was found
(p < 0.05) in the level of PPAR-g in monocyte cultures, and
the groups with curcumin showed the higher level of
PPAR-g.
Compared to the control group, there was a significant
difference (p < 0.05) in the level of NF-kB p50 in monocyte
cultures, and the groups with curcumin showed the lower
level of NF-kB p50. Furthermore, there was significant
differences between doses of 10mM and 100mM curcumin
and those doses between 30mM and 100mM of curcumin,
whereas there was no significant difference with those
doses between 10mM and 30mM (p > 0.05), as shown in Fig. 2
or Table S2 in the supplementary material online.
The effect of giving various doses of curcumins on
the level of proinflammatory cytokines (IL-1a, IL-6,
and TNF-a) in monocyte cultures after
preeclamptic plasma exposure
In Step 2 of the study, compared to the control group, there
was significant differences in the level of IL-1a in monocyte
cultures treated with 30mM and 100mM doses of curcumin
after preeclamptic plasma exposure, which showed the
lower level. Furthermore, there was a significant difference
between curcumin doses of 10mM and 30mM, and between
doses of 10mM and 100mM doses.
Compared to the control group, there was significant
differences in the level of IL-6 (p < 0.05) in monocyte
cultures receiving a 100mM dose of curcumin, whereas the
culture receiving curcumin had the lower level. Between
each group of various doses of curcumin, there was a sig-
nificant difference (p < 0.05) in the level of IL-6.
Compared to the control group, there was a significant
difference in the level of TNF-a from monocyte culture
Figure 1 Histogram shows comparison of (A) IL-1a, (B) IL-6,
and (C) TNF-a levels in monocyte cultures treated with
various doses of curcumins for 1 hour and then exposed to
preeclamptic plasma (15%) and incubated for 48 hours. The
same letter means there was no significant difference
(p > 0.05). ILZ interleukin; TNF-aZ tumor necrosis factor a.
Table 2 Comparison of IL-1a, IL-6, TNF-a, PPARg, and
nuclear NF-kB p50 levels in monocyte cultures exposed to
normotensive pregnancy plasma with those exposed to se-
vere preeclamptic plasma, both incubated for 48 hours.
Variables
(pg/mL)
Incubation for 48 h p
Normotensive
(mean  SD)
Severe preeclamptic
(mean  SD)
Levels of IL-1a 88.90  6.95 116.22  29.24 0.005
Levels of IL-6 14.70  8.30 36.07  16.22 0.001*
Levels of TNF-a 19.38  5.29 27.69  13.36 0.058
Levels of PPAR-g 0.67  0.10 0.46  0.05 <0.001*
Levels of nuclear
NF-kBp50
2.57  0.49 3.03  0.56 0.043*
*A p value < 0.05 means that there is a significant difference.
IL Z interleukin; NF-kB Z nuclear factor kappa beta;
PPAR-g Z peroxisome proliferator-activated receptor g;
TNF-a Z tumor necrosis factor a.
Transcription factors NF-kB and PPAR-g 109receiving 10mM, 30mM, and 100mM doses of curcumins, as
the groups receiving curcumins showed a lower level. Be-
sides, between each groups of various doses, there was a
significant difference in the level of TNF-a, as shown in
Fig. 3 or Table S3 in the supplementary material online.
The effect of giving various doses of curcumins on
the level of PPAR-g and the level of nuclear NF-kB
p50 in monocyte cultures after preeclamptic
plasma exposure
Compared to the control group, there was significant dif-
ference in the level of PPAR-g in monocyte cultures after
preeclamptic plasma exposure, whereas monocyte cultures
with curcumin showed a higher level. Besides, there was a
significant difference between curcumin doses of 10mM and
100mM, and between doses of 30mM and 100mM. Meanwhile,
there was no significant difference between doses of 10mM
and 30mM (p > 0.05).
Nevertheless, there was also significant difference
(p < 0.05) in the level of nuclear NF-kB p50 in monocyte
cultures treated with curcumin doses of 100mM after pre-
eclamptic plasma exposure, and the culture with curcumin
showed a lower level. Besides, there was significant dif-
ference between curcumin treatment by doses of 10mM and
100mM, and between doses of 30mM and 100mM. Between
doses of 30 mM and 100 mM, there was no significant dif-
ference (p > 0.05) as shown in Fig. 4 or Table S4 in the
supplementary material online.
Path analysis
A theoretical path analysis model describes the correlation
between each variable, which were curcumin, level of
PPAR-g, nuclear NF-kB p50, IL-6, IL-1f, and the level of
TNF-f, as shown in Fig. 5.
As seen in Table 3 a significant correlation was found
between each variable used in Step 1 of this study, which
showed that the analysis of this study could be furtherdescribed with path analysis. A path diagram describes the
path coefficient and relation of causal agents, as well as
error coefficient, explaining that curcumin has equally
direct effects on the level of PPAR-g to each other, and
contrasting direct effect on the level of nuclear NF-kB p50
as shown in Fig. 6.
In Step 1 this study, as shown in Tables 4 and 5, it showed
that the direct effect of curcumin on the level of nuclear
NF-kB p50 was not statistically significant, whereas the in-
direct effect of curcumin on the level of nuclear NF-kB p50
through alteration of PPAR-g level was statistically
significant.
Figure 2 Histogram shows comparison of (A) PPAR-g and (B)
nuclear NF-kB p50 level in monocyte cultures treated with
curcumins for 1 hour and then exposed to preeclamptic plasma
(15%) and incubated for 48 hours. The same letter means there
was no significant difference (p > 0.05). NF-kB Z nuclear
factor kappa beta; PPAR-g Z peroxisome proliferator-
activated receptor g.
Figure 3 Histogram shows comparison of (A) IL-1a, (B) IL-6,
and (C) TNF-a levels in monocyte cultures exposed to pre-
eclamptic plasma (15%), incubated for 48 hours, and then
treated with various doses of curcumins. The same letter
means there was no significant difference (p > 0.05).
IL Z interleukin; TNF-a Z tumor necrosis factor a.
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found between each variable used in Step 2 of this study,
which showed that the analysis of this study could be
further described with path analysis. A path diagram de-
scribes the path coefficient and relation of causal agents,
as well as error coefficient, explaining that curcumin has an
equally direct effect on the level of PPAR-g to each other,
and contrasting direct effect on the level of NF-kB p50.
In Step 2 of this study a strong significance was found in
the direct effect of curcumin toward the decreased level of
NF-kB p50 than its indirect effect, as shown in Tables 7 and 8.
It means that after the preeclamptic plasma exposure, the
curcumin directly affected the alteration level of nuclear
NF-kB p50 and decrease of proinflammatory cytokines (IL-6,
IL-1f, and the level of TNF-f) as shown in Fig. 7.
In Steps 1 and 2 of this study, it is shown that curcumin
significantly decreases the levels of proinflammatory cyto-
kines such as IL-1a, IL-6, and TNF-a in monocyte cultures
that were exposed to preeclamptic plasma. If curcumin was
given in monocyte cultures prior to preeclamptic plasma
exposure, the direct effect of curcumin on the level of
nuclear NF-kB p50 was not significant compared to indirect
effects through the level of PPAR-g. But if the curcumin was
given in monocyte cultures after preeclamptic plasmaexposure, direct effects on the level of nuclear NF-kB p50
was significant compared with indirect effect through the
level of PPAR-g.Discussion
Various concepts of the pathogenesis of preeclampsia have
been widely described, but the characteristics of pre-
eclampsia remain the same: an excessive systemic inflam-
mation and endothelial dysfunction.4,5,8,9 Cytokines are
messengers of the inflammatory cascade with TNF-a, IL-1b,
IL-6, and IL-8 acting synergistically. An increase in the
levels of TNF-a and IL-1b have been reported in pre-
eclampsia. The pathomechanism of preeclampsia is closely
related to leukocyte activation. The consequence of the
activation is the release of proinflammatory cytokines, the
Figure 4 Histogram shows comparison of (A) PPAR-g and (B)
nuclear NF-kB p50 levels in monocyte cultures treated with
curcumins for 1 hour after preeclamptic plasma exposure, and
incubated for 48 hours. The same letter means there was no
significant difference (p > 0.05). NF-kBZ nuclear factor kappa
beta; PPAR-g Z peroxisome proliferator-activated receptor g.
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finally vascular dysfuction.14 Previous reports demonstrated
increased activation of L-selectin of neutrophils, mono-
cytes, and T-cells in women with preeclampsia compared
with those with normotensive pregnancy. The increase is
related to the rise of NF-kB translocation to the nucleus and
rise of IL-6. Another study reported the stimulation of NF-
kB activation and expression of COX-2 on vascularization ofFigure 5 Path diagram in correlation model between cur-
cumin (X1), the level of PPARg (Y1), the level of nuclear NF-kB
p50 (Y2), the level of IL-6 (Y3), the level of IL-1a (Y4), and the
level of TNF-a (Y5). IL Z interleukin; NF-kB Z nuclear factor
kappa beta; PPAR-g Z peroxisome proliferator-activated re-
ceptor g; TNF-a Z tumor necrosis factor a.preeclamptic mothers, that was relevant to the neutrophil
infiltration.40
This reportwas supported by an in vitro study of Cindrova-
Davies.41 The study demonstrated the elevation of NF-kB and
intercellular adhesion molecule 1 expression within Human
Umbilical Vein Endothelial Cells (HUVEC) media exposed to
preeclamptic plasma. This effect was blocked by vitamin E
and N-acetyl-cystein administration. The suppressive effect
of NF-kB activation by vitamins was triggered by antioxidant
activation from those vitamins.41 Both monocyte and
lymphocyte-T have high activities of NF-kB in PBMC of pa-
tientswith preeclampsia. IL-6 is also suggested to have a high
activation of NF-kBwith abundant levels in the plasma.5,10,12
In this study, monocyte cultures derived from the
isolation of monocytes of peripheral blood circulation were
used to study the inflammatory response in preeclampsia.
This was in contrast to other researchers such as Faas
et al,16 who used monocyte cell line (monomac-6/MM6) in
their study of monocyte activation in preeclampsia. Faas
et al16 assumed that the monocyte cell line had functional
and phenotypic characteristics similar to those of mature
monocytes, whereas isolation of monocytes from peripheral
blood already results in activation of the monocytes. But
some other researchers used monocyte cultures derived
from the isolated monocytes of peripheral blood in their
studies of the inflammatory response in preeclampsia.10,19
Table 2 shows a significant difference in the levels of
nuclear NF-kB p50 in monocyte cultures stimulated by
normotensive pregnancy plasma and severe preeclamptic
plasma. Similarly, there were significant differences in the
levels of proinflammatory cytokines IL-1a, IL-6, and TNF-a,
whereas monocyte cultures stimulated with severe pre-
eclamptic plasma had higher levels. This was supported by
the data of this study that, upon stimulation of the mono-
cytes, there were increased levels of nuclear NF-kB p50,
subsequently followed by increased levels of cytokines IL-
1a, IL-6, and TNF-a. Interpretatively, there was a higher
inflammatory response in monocyte cultures stimulated by
severe preeclamptic plasma and there was a higher acti-
vation of NF-kB transcription factor as well.
In Step 1 of the study, several doses of curcumins were
given to monocyte cultures to find its effect onTable 3 Correlation coefficient regarding the significance
level in Step 1 of the study.
Intermediate coefficient Correlation
coefficient (r)
p
Curcumin Level of PPAR-g 0.855 <0.001*
Level of nuclear
NFkBp50
0.853 <0.001*
Level of PPAR-g Level of nuclear
NF-kB p50
0.982 <0.001*
Level of
nuclear
NF-kBp50
Level of IL-6 0.631 0.005*
Level of IL-1a 0.648 0.004*
Level of TNF-a 0.641 0.001*
*A p value < 0.05 means that there is a significant difference.
IL Z interleukin; NF-kB Z nuclear factor kappa beta;
PPAR-g Z peroxisome proliferator-activated receptor g;
TNF-a Z tumor necrosis factor a.
Figure 6 Path diagram between all variables with error co-
efficient in Step 1 of the study.
Table 4 The direct effect of curcumin on the levels of
PPAR-g and nuclear NF-kB p50 in Step 1 of the study.
Direct effects p
Effect coefficient Effect toward
Curcumin 0.855 Level of PPAR-g <0.001*
0.049 Level of nuclear
NF-kB p50
0.609
*A p value <0.05 means that there is a significant difference.
NF-kB Z nuclear factor kappa beta; PPAR-g Z peroxisome
proliferator-activated receptor g.
112 B. Rahardjo et al.proinflammatory cytokines prior to the exposure to pre-
eclamptic plasma. Decreased levels of IL-1a, IL-6, and TNF-
a were found. There was decreasing IL-1a compared to
those with control especially in 100mM doses. A decreased
level of IL-1a is equal to the increased dose of curcumin
although it was not statistically significant. There was a
decreasing level of IL-6 significantly at doses of 30mM, and a
decreased level of TNF-a in monocyte cultures was found
significantly at doses of 30mM and 100mM. It is concluded
that curcumin decreased proinflammatory cytokines (IL-1a,Table 5 Indirect effect of curcumin on the level of nu-
clear NF-kB p50, IL-6, IL-1a, and TNF-a in Step 1 of the
study.
Variable Indirect effects Total
Through Effect
coefficient
Effect
toward
Curcumin Level of PPAR-g 0.804 Level of
nuclear
NFkB p50
0.853
Level of nuclear
NF-kB p50
0.031 Level of
IL-6
0.031
Level of nuclear
NF-kB p50
0.031 Level of
IL-1a
0.031
Level of nuclear
NF-kB p50
0.031 Level of
TNFa
0.031
IL Z interleukin; NF-kB Z nuclear factor kappa beta; TNF-
a Z tumor necrosis factor a.IL-6, and TNF-a), which is relevant with some previous
studies when curcumin has its anti-inflammatory effect to
decrease proinflammatory cytokines. As described previ-
ously, curcumin had some targets, such as growth factors,
growth factor receptors, transcription factors, cytokines,
enzymes, and apoptosis regulator genes.38,39,42,43
Gautam and Jachak44 demonstrated decreased levels of
IL-1b and TNF-a in mice suffering from chronic inflamma-
tion. By in vitro study, it is shown that a level of 5mM cur-
cumin at can inhibit the production of TNF-a and IL-1 by
human monocyte induced by Lipopolysaccharide (LPS). It is
concluded that curcumin can decrease the level of proin-
flammatory cytokines in monocyte cultures of nonpregnant
women stimulated by preeclamptic plasma. The decrease
was equal to the increasing doses of curcumin, except IL-6
did not show the same pattern.
In this study, the treatment of curcumin also affected
transcription factors which had a significant role in proin-
flammatory cytokine synthesis, that are NF-kB and PPAR-g.
We found more decreased levels of nuclear NF-kB p50 in
monocyte cultures treated with curcumin than those
without any treatment of curcumin. A significant difference
was found in doses of 100mM, whereas those with other
doses showed insignificant decreases.
Biswas and Rahman,45 reported that the inhibition of NF-
kB activation is performed by the inactivation of regulatory
Ik-Ba kinase, blocking of NF-kB to DNA, as inhibition of
phosphorylation and degradation of IKBa as well as trans-
location of p65 NF-kB. Curcumin basically inhibits NF-kB
transactivaton by inhibiting nuclear translocation of sub-
unit p65 NF-kB in its relation of sequential suppression of
Ik-Ba kinase phosphorylase, degradation of IkBa, phos-
phorylase of p65, and acetylation of p65. NF-kB regulates
many gene expressions that have a role in the inflammation
process. In this field, it is now considered that NF-kB inhi-
bition by curcumin has a potential role in the treatment of
chronic inflammation.45e47
Furthermore, in this study a significant decrease of nu-
clear NF-kB p50 was found; this is possibly due to inacti-
vation IKKb so that NF-kB is persistently bound to IkB. In
other pathways, curcumin blocks the translocation of NF-kB
p50 actively to the nucleus. This should be studied furtherTable 6 Correlation coefficient regarding the significance
level in Step 2 of the study.
Intermediate coefficient Correlation
coefficient (r)
p
Curcumin level of PPAR-g 0.794 <0.001*
Level of nuclear
NF-kB p50
0.904 <0.001*
Level of
PPAR-g
Level of nuclear
NF-kB p50
0.916 <0.001*
Level of
nuclear
NF-kB p50
Level of IL-6 0.981 <0.001*
Level of IL-1a 0.944 <0.001*
Level of TNFa 0.930 <0.001*
*A p value < 0.05 means that there is a significant difference.
IL Z interleukin; NF-kB Z nuclear factor kappa beta;
PPAR-g Z peroxisome proliferator-activated receptor g;
TNF-a Z tumor necrosis factor a.
Table 7 The direct effect of curcumin on the level of
PPARg and nuclear NF-kB p50 in Step 2 of the study.
Direct effects p
Effect
coefficient
Effect toward
Curcumin 0.794 Level of PPAR-g <0.001*
0.478 Level of nuclear
NFkB p50
0.001*
*A p value < 0.05 means that there is a significant difference.
NF-kB Z nuclear factor kappa beta; PPAR-g Z peroxisome
proliferator-activated receptor g.
Figure 7 Path diagram between all variables with error co-
efficient in Step 2 of the study.
Transcription factors NF-kB and PPAR-g 113by measuring the activity of IKKb and also by tracing the
expression of NF-kB p50 within cytoplasm, or it can be
observed by confocal microscope to see the active move-
ment of NF-kB into the nuclei.
The increased PPAR-g found in monocyte cultures with
curcumin treatment was equal to the dose of curcumin
given. The increase of PPAR-g was found significantly by the
doses of 10mM, 30mM, and 100mM of curcumin. The increase
of this PPAR-g was equal to the decrease of nuclear NF-kB
p50. In the study of mice with sepsis condition, curcumin
was administered for 3 days with a dose of 0.24 mmol/
bodyweight, there was 45% increased mRNA of PPAR-g and
65% increase of PPAR-g proteins. In an in vitro study with
immunohistochemistry, the antibody of PPAR-g on the cells
with 100mM curcumin, there was 125% increased PPAR-g.
This result indicates the advantageous effect of curcumin
as an anti-inflammatory agent by upregulation of PPAR-g.
This positive effect of PPAR-g ligand is related to the
diminished IKb kinase complex, JNK activation, and
reduced NF-kB and AP-1 pathway. The evidence showed
that PPAR-g ligand affected cancerous cells by PPAR-g
phosphorylase so there was interaction with subunit p65 of
NF-kB. As a consequence, there was inactivation of NF-kB
pathway. The inhibition of cell signaling pathway as Akt,
NF-kB, AP-1, or JNK is the one of mechanisms of performingTable 8 Indirect effect of curcumin on the level of nu-
clear NF-kB p50, IL-6, IL-1a, and TNF-a in Step 2 of the
study.
Variable Indirect effects Total
Through Effect
coefficient
Effect
toward
Curcumin Level of PPAR-g 0.256 Level of
nuclear
NF-kB p50
0.222
Level of nuclear
NF-kB p50
0.469 Level of
IL-6
0.469
Level of nuclear
NF-kB p50
0.451 Level of
IL-1a
0.451
Level of nuclear
NF-kB p50
0.445 Level of
TNF-a
0.445
IL Z interleukin; NF-kB Z nuclear factor kappa beta;
PPAR-g Z peroxisome proliferator-activated receptor g;
TNF-a Z tumor necrosis factor a.apoptosis induced by curcumin. The anti-inflammatory ef-
fect of curcumin by PPAR-g upregulation is closely related
to NF-kB pathway.48,49
Based on the correlation, there was a significant corre-
lation among the variables. Therefore analysis was
continued with path analysis. It describes path coefficients
and causative relations as well as effects including error
coefficient between curcumin, level of PPAR-g, level of
nuclear NF-kB p50, and the levels of IL-1a, IL-6, and TNF-a.
By path analysis, it was shown that curcumin affected the
levels of proinflammatory cytokines indirectly for IL-1a, IL-
6, and TNF-a. As the level of nuclear NF-kB p50 decreased,
the levels of IL-1a, IL-6, and TNF-a decreased after cur-
cumin treatment. It clearly demonstrated that curcumin
affected proinflammatory cytokine levels by inhibitory ac-
tion to transcription factor NF-kB, which was where we
examined the level of nuclear NF-kB p50. The activation of
NF-kB is triggered by IKKb activity as well as NF-kB p50
active translocation located within the cytoplasm. In this
study, the data related to the activity of IKK or trans-
location of NF-kB need further research to reveal its
mechanism.
The difference in Step 1 of the study, related to the time
of preeclamptic plasma exposure, in Step 2 of the study
showed that the treatment of curcumin in various doses
(doses 10mM, 30mM, and 100mM) after the preeclamptic
plasma exposure decreased the level of IL-1a significantly
at doses of 30mM and 100mM, whereas there was signifi-
cantly decreased level of IL-6 at doses of 100mM. A signifi-
cant decreased level of TNF-a was found at doses of 10mM,
30mM, and 100mM. Those findings clearly explained that
curcumin treatments in various doses could decrease
proinflammatory levels in a monocyte culture that has been
already stimulated with preeclampsia conditions. However,
the decrease showed significance only in higher doses of
curcumins given, whereas in lower doses of curcumin, the
level of IL-1a and IL-6 was still in upper limits. In TNF-a, the
decreased level of TNF-a is equal to the increased dose of
curcumin given to monocyte cultures.
Finally, it was revealed in this study that curcumin could
decrease proinflammatory cytokines in monocyte cultures
exposed by preeclamptic plasma. The difference between
Steps 1 and 2 of the study was in the transduction signaling
pathway of production and synthesis of proinflammatory
114 B. Rahardjo et al.cytokines (IL-1a, IL-6, and TNF-a). From both steps of this
study it was found that curcumin decreases the production
of proinflammatory cytokines indirectly by the decreased
level of nuclear NF-kB p50, whereas the direct effect of
curcumin to the decreased level of nuclear NF-kB p50 was
significantly strong if curcumin was treated to monocyte
cultures after preeclamptic plasma exposure rather than
those prior to exposure. But if curcumin was given to
monocyte cultures prior to preeclamptic plasma exposure,
curcumin indirectly influenced the level of nuclear NF-kB
p50 by the increased level of PPAR-g significantly.
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